Cartherics and Catalent Extend Scope of Existing Commercial Licensing Agreement Cartherics Pty Ltd, a clinical-stage biotechnology company focused on developing next-generation immune cell therapies for high-impact women’s health conditions, has announced an expanded strategic partnership with Catalent, Inc., a global…
Virica Biotech and FUJIFILM Biosciences Team Up to Advance AAV Production Enhancers Through Canada–Japan Co-Innovation Initiative Virica Biotech, a biotechnology firm focused on improving viral vector manufacturing through its proprietary Viral Sensitizer Enhancer (VSE™) technology, has announced a new international…
Adagio Medical Secures U.S. Food and Drug Administration IDE Approval to Study Its Next-Generation vCLAS® Ventricular Ablation System Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio”), a medical technology company focused on advancing catheter-based ablation solutions for cardiac arrhythmias, has announced…
Sidewinder Therapeutics Secures $137 Million Series B to Advance Precision Bispecific ADCs into Clinical Development for Cancer Sidewinder Therapeutics, a biopharmaceutical company focused on advancing next-generation antibody-drug conjugates (ADCs) for oncology, has announced the successful closing of an oversubscribed $137…
Allergan Aesthetics Launches Its Third Advanced AMI Training Center in Austin Allergan Aesthetics, a leading global provider of aesthetic medicine solutions and part of AbbVie, has announced the opening of its newest Allergan Medical Institute (AMI) Training Center in Austin.…
Biocon Announces U.S. Commercial Debut of Bosaya™ and Aukelso™, Its Denosumab Biosimilars Biocon Limited, a global innovation-driven biopharmaceutical organization, has announced the commercial launch of two denosumab biosimilars—Bosaya™ and Aukelso™—in the United States, marking a significant expansion of its biosimilars…
B Capital Selected by AMED as Registered VC to Advance Japan’s Drug Development Ecosystem B Capital, a multi-stage investment firm with a strong focus on healthcare innovation, has announced that it has been officially selected as a registered venture capital…
Amy Koch Joins Propel Health Medical Affairs as Senior Vice President, Client Services Propel Health Medical Affairs (PHMA), a full-service scientific communications agency operating within the broader Propel Health ecosystem, has announced the appointment of Amy Koch as Senior Vice…
Stoke Therapeutics Announces Appointment of Dr. Clare Kahn to Its Board of Directors Stoke Therapeutics, a clinical-stage biotechnology company focused on restoring protein expression through RNA-based medicines, has announced the appointment of Clare Kahn, Ph.D., to its Board of Directors.…
CareQuest Institute Appoints An Nguyen, DDS, MPH, to Serve as Chief Clinical Officer CareQuest Institute for Oral Health has announced the appointment of An Nguyen, DDS, MPH, as its new Chief Clinical Officer, marking a significant leadership addition as the…
Frazier Life Sciences brings on Christian Schade as Senior Advisor to strengthen strategic expertise Frazier Life Sciences (FLS), a well-established investment firm dedicated to advancing innovative biopharmaceutical companies, has announced the appointment of Christian Schade as Senior Advisor. In this…
Glaukos to Showcase Multiple Scientific Abstracts at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting Glaukos Corporation (NYSE: GKOS), a leading innovator in ophthalmic pharmaceuticals and medical devices, has announced its prominent participation in the upcoming American…